<SEC-DOCUMENT>0001628280-23-013290.txt : 20230426
<SEC-HEADER>0001628280-23-013290.hdr.sgml : 20230426
<ACCEPTANCE-DATETIME>20230426172234
ACCESSION NUMBER:		0001628280-23-013290
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230426
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Cost Associated with Exit or Disposal Activities
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230426
DATE AS OF CHANGE:		20230426

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SANGAMO THERAPEUTICS, INC
		CENTRAL INDEX KEY:			0001001233
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				680359556
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30171
		FILM NUMBER:		23850889

	BUSINESS ADDRESS:	
		STREET 1:		7000 MARINA BLVD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		5109706000

	MAIL ADDRESS:	
		STREET 1:		7000 MARINA BLVD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANGAMO BIOSCIENCES INC
		DATE OF NAME CHANGE:	20000208
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sgmo-20230426.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:e910dcf1-bc7b-4985-9ec4-9288f5bc8fbc,g:43bd102d-e07e-4bef-8a75-88648a1bc7f2,d:45ed14efba074848ad46c48b08c5c7d5--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sgmo-20230426</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i2ef6b1eb8e4449539b132b573bb052e5_D20230426-20230426" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjQ1ZWQxNGVmYmEwNzQ4NDhhZDQ2YzQ4YjA4YzVjN2Q1L3NlYzo0NWVkMTRlZmJhMDc0ODQ4YWQ0NmM0OGIwOGM1YzdkNV80L2ZyYWc6NmM4NWRhOTUzNGQ3NGZjYjllODQwMmExOGExM2NmNjcvdGFibGU6MTU4Mzg3NTEzNWI0NDY0NDhkNTYwZmQxNzNlMTM3YzcvdGFibGVyYW5nZToxNTgzODc1MTM1YjQ0NjQ0OGQ1NjBmZDE3M2UxMzdjN18yLTEtMS0xLTc2NTc0_cc3b0c1a-cba3-43aa-ae5f-21fb4288f5b1">April 26, 2023</ix:nonNumeric><ix:nonNumeric contextRef="i2ef6b1eb8e4449539b132b573bb052e5_D20230426-20230426" name="dei:EntityCentralInd